Simplex Trading, LLC Allovir, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$2.15 - $3.64 $3,579 - $6,060	1,665 New	1,665 $3,000
Q1 2023 Apr 27, 2023	SELL	$3.94 - $7.05 $11,461 - $20,508	-2,909 Reduced 54.12%	2,466 $9,000
Q4 2022 Feb 02, 2023	BUY	$4.7 - $9.98 $22,536 - $47,854	4,795 Added 826.72%	5,375 $27,000
Q3 2022 Nov 04, 2022	BUY	$4.13 - $8.79 $2,395 - $5,098	580 New	580 $4,000
Q1 2022 May 02, 2022	SELL	$6.75 - $13.52 $58,617 - $117,407	-8,684 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$12.94 - $25.99 $111,076 - $223,098	8,584 Added 8584.0%	8,684 $112,000
Q2 2021 Aug 12, 2021	SELL	$19.44 - $25.06 $8,631 - $11,126	-444 Reduced 81.62%	100 $1,000
Q1 2021 Apr 26, 2021	BUY	$20.81 - $45.5 $11,320 - $24,752	544 New	544 $12,000
Q4 2020 Feb 02, 2021	SELL	$23.94 - $46.81 $2,848 - $5,570	-119 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$21.05 - $42.7 $2,504 - $5,081	119 New	119 $3,000

44.4M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $933M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.